NCT03768024View on ClinicalTrials.gov

A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be Abused

PHASE1CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

June 21, 2007

Primary Completion Date

October 25, 2007

Study Completion Date

October 25, 2007

Conditions

PainAcute Pain

Interventions

DRUG

GRT0151Y 50 mg capsule

GRT0151Y 50 mg capsule

DRUG

Hydromorphone IR 4 mg

Hydromorphone IR 4 mg tablet (encapsulated)

DRUG

Matching placebo

Matching placebo

Trial Locations (1)

M5V 2T3

DecisionLine Clinical Research Corporation, Toronto

Sponsors

Lead Sponsor

Grünenthal GmbH

All Listed Sponsors

lead

Grünenthal GmbH

INDUSTRY